Literature DB >> 2685656

Metastatic anaplastic oligodendroglioma.

D R Macdonald1, R A O'Brien, J J Gilbert, J G Cairncross.   

Abstract

We report 7 patients, ages 21 to 49 years, with systemic metastasis from anaplastic oligodendroglioma. Metastases developed in the scalp, cervical lymph nodes, bone, and other organs 1 to 76 months after the most recent surgery and 18 to 86 months after diagnosis. Systemic metastases responded to focal radiotherapy or nitrosourea-based chemotherapy for 6 to 18 months. Five patients have died, 4 to 24 months after the appearance of systemic metastases, all with progressive cerebral and systemic tumor. We observed 2 distinct patterns of spread of oligodendroglioma. Pattern 1, initial scalp or regional lymph node involvement followed by distant metastasis, was associated with multiple craniotomies. Pattern 2, distant metastasis without scalp or regional lymph node spread, was associated with early radiotherapy and chemotherapy. Longer-than-expected survival was not essential to metastasis. We speculate that anaplastic oligodendrogliomas possess special characteristics favoring metastasis and that early aggressive treatment alters the biology of this disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2685656     DOI: 10.1212/wnl.39.12.1593

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Extradural cord compression due to metastatic oligodendroglioma.

Authors:  Jeff Garner; Yehya Morcos; Mohammed Bari
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

2.  Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression.

Authors:  A F Chambers; G H Denhardt; S M Wilson; J G Cairncross
Journal:  J Neurooncol       Date:  1991-08       Impact factor: 4.130

3.  Extraneural metastasis in intracranial tumors in children: the experience of a single center.

Authors:  Ali Varan; Neriman Sari; Nejat Akalan; Figen Söylemezoğlu; Canan Akyüz; Tezer Kutluk; Münevver Büyükpamukçu
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

4.  Combined treatment modality for anaplastic oligodendroglioma: a phase II study.

Authors:  B Jeremic; Y Shibamoto; D Gruijicic; B Milicic; M Stojanovic; N Nikolic; A Dagovic; J Aleksandrovic
Journal:  J Neurooncol       Date:  1999-06       Impact factor: 4.130

5.  Oligodendroglioma metastatic to bone marrow.

Authors:  Firas Al-Ali; Aaron J Hendon; Marcia K Liepman; Jennifer L Wisniewski; Mark J Krinock; Kevin Beckman
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

6.  Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide.

Authors:  Fulin Wang; Guangyu Qiao; Xin Lou
Journal:  J Neurooncol       Date:  2010-12-29       Impact factor: 4.130

7.  1p/19q chromosome deletions in metastatic oligodendroglioma.

Authors:  Ryan Merrell; L Burton Nabors; Arie Perry; Cheryl Ann Palmer
Journal:  J Neurooncol       Date:  2006-05-19       Impact factor: 4.130

Review 8.  A survey of metastatic central nervous system tumors to cervical lymph nodes.

Authors:  Vanni Mondin; Alfio Ferlito; Kenneth O Devaney; Julia A Woolgar; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-08       Impact factor: 2.503

9.  The treatment of cerebral oligodendrogliomas with particular reference to features indicating malignancy: report of seventy-seven cases.

Authors:  M Turgut; K Tahta; O E Ozcan; B Onol
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

10.  Molecular genetic study of a metastatic oligodendroglioma.

Authors:  M T Giordana; C Ghimenti; E Leonardo; I Balteri; M Iudicello; D Duò
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.